This announcement is a separate document:
ノイルイミューン・バイオテック：[遅れました] NIB102とNIB103のライセンス契約の終了に関する補足コメント
Noile-Immune Biotech: [Delayed]Supplemental Comments on the Termination of the License Agreements for NIB102 and NIB103
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.